Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Modex Plans To Move EPO Cell Therapy Into Phase II

March 21, 2001

By Cormac Sheridan

Pantheco Raises DKK53.7M, Licenses PNA Technology

March 7, 2001

By Cormac Sheridan

Bavarian Nordic Licenses Vaccine Technology From Australian Firm

Feb. 7, 2001

By Cormac Sheridan

Bavarian Nordic Licenses Vaccine Technology From Australian Firm

Feb. 7, 2001

By Cormac Sheridan

Austrian Company Intercell Raises EUR27M For Synthetic Vaccines

Jan. 17, 2001

By Cormac Sheridan

Austrian Company Intercell Raises EUR27M For Synthetic Vaccines

Jan. 17, 2001

By Cormac Sheridan

Combio Spun Off From Carlsberg To Develop Chemistry Platform

Jan. 10, 2001

By Cormac Sheridan

Combio Spun Off From Carlsberg To Develop Chemistry Platform

Jan. 10, 2001

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 1, 2025.
Novo Nordisk licenses Lexicon’s preclinical obesity drug in $1B deal
BioWorld Science
As companies continually search for next-generation obesity prospects, one of the leaders in the disease space, Novo Nordisk A/S, has obtained an exclusive...
Corcept looks to NDA following strong phase III ovarian cancer data
BioWorld
Relacorilant, a cortisol modulator from Corcept Therapeutics Inc., produced new and strong phase III results in treating platinum-resistant ovarian cancer. The...
Otsuka submits first BLA to FDA for sibeprenlimab in IgAN
BioWorld
Otsuka Pharmaceutical Development & Commercialization Inc. filed its BLA with the U.S. FDA for sibeprenlimab to treat immunoglobulin A nephropathy (IgAN). The...